Abstract

Minoxidil 50 mg/mL in Espumil Foam Base

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2018 - Volume 22, Number 4

Page(s): 322

Download in electronic PDF format for $75
  • Minoxidil 50 mg/mL in Espumil Foam Base Page 1

Abstract

A formulation for preparing Minoxidil 50 mg/mL in Espumil Foam Base. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • minoxidil
  • hair growth stimulant
  • antihypertensive agent
  • high blood pressure
  • topical preparation
  • transdermal administration
  • lipophilic foam
  • scalp

Related Categories

  • DERMATOLOGY
  • FORMULATIONS
  • CARDIOLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2018
Pg. 322
Minoxidil 50 mg/mL in Espumil Foam Base
Author(s): Allen Loyd V Jr
May/Jun 2021
Pg. 236-240
Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design
Author(s): Lupatini Rodrigo, Sidhu Raman, Patel Harshad, Bichar Katia
Jul/Aug 2013
Pg. 312-322
Basics of Compounding: Foam Dosage Forms
Author(s): Allen Loyd V Jr
Mar/Apr 2013
Pg. 165-167
Stability of Minoxidil in Espumil Foam Base
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Sep/Oct 2023
Pg. 386-395
Basics of Compounding: Compounding Foams
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2019
Pg. 57
Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 69-76
Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution
Author(s): Marotta James C, Patel Gopesh, Carvalho Maria, Blakeney Samantha
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Mar/Apr 2020
Pg. 98-102
Compounding Pearls -- Wound Care: Base Selection
Author(s): Riepl Mike
Jul/Aug 2023
Pg. 340-346
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Author(s): Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
May/Jun 2023
Pg. 256-262
Extemporaneous Topical Minoxidil Solutions for the Treatment of Alopecia: Stability Studies and Incorporation Tests of Active Ingredients in ALOPLUS FAST Base
Author(s): Spennacchio Antonio, Lopedota Angela Assunta, Lopalco Antonio, Dibenedetto Maria Teresa, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
Sep/Oct 2019
Pg. 413
Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 240-241
Updated Stability Data for Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSpend SF and Minoxidil in Espumil
Author(s): Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid
Nov/Dec 2022
Pg. 480-488
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Author(s): Riepl Mike
May/Jun 2005
Pg. 215-218
Basics of Compounding for Hair Care -- Part 2: Medicated Conditions
Author(s): Fonseca Simonne C
Sep/Oct 2008
Pg. 392-397
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Author(s): Mixon William, Helms Scott R